Detalhe da pesquisa
1.
Favorable overall survival with imetelstat in relapsed/refractory myelofibrosis patients compared with real-world data.
Ann Hematol
; 101(1): 139-146, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34622316
2.
Imetelstat in intermediate-2 or high-risk myelofibrosis refractory to JAK inhibitor: IMpactMF phase III study design.
Future Oncol
; 18(22): 2393-2402, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35510486
3.
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study.
Lancet
; 387(10020): 770-8, 2016 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26673811
4.
Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL.
Blood
; 126(16): 1893-901, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26232170
5.
BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells.
Blood
; 116(22): 4621-30, 2010 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-20724541
6.
Repression of BMI1 in normal and leukemic human CD34(+) cells impairs self-renewal and induces apoptosis.
Blood
; 114(8): 1498-505, 2009 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-19556423
7.
Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis.
J Clin Oncol
; 39(26): 2881-2892, 2021 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34138638
8.
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study.
J Clin Oncol
; 39(1): 48-56, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33108243
9.
Establishing long-term cultures with self-renewing acute myeloid leukemia stem/progenitor cells.
Exp Hematol
; 35(10): 1538-49, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17889721
10.
Long-term maintenance of human hematopoietic stem/progenitor cells by expression of BMI1.
Blood
; 111(5): 2621-30, 2008 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18156489
11.
Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche?
Hum Mol Genet
; 15 Spec No 2: R210-9, 2006 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16987886